High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis
Authors
Keywords
c-Met, Colorectal cancer, Prognosis, Meta-analysis
Journal
TUMOR BIOLOGY
Volume 36, Issue 2, Pages 515-520
Publisher
Springer Nature
Online
2015-01-31
DOI
10.1007/s13277-014-2659-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase Ib study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC.
- (2017) E. Tan et al. JOURNAL OF CLINICAL ONCOLOGY
- Multivariate Analysis of Molecular Indicators for Postoperative Liver Metastasis in Colorectal Cancer Cases
- (2013) Li-Yuan Qian et al. Asian Pacific Journal of Cancer Prevention
- c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis
- (2013) Shan Yu et al. PLoS One
- Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis—correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met
- (2013) Alexandros Garouniatis et al. TUMOR BIOLOGY
- FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk
- (2012) Alexandros Garouniatis et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation
- (2012) Abbas K. Samadi et al. TUMOR BIOLOGY
- Coexpression of Activated c-Met and Death Receptor 5 Predicts Better Survival in Colorectal Carcinoma
- (2011) Shahab Uddin et al. AMERICAN JOURNAL OF PATHOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer?
- (2011) Alessandro Inno et al. Clinical Colorectal Cancer
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Clinicopathologic and Molecular Features of Epidermal Growth Factor Receptor T790M Mutation and c-MET Amplification in Tyrosine Kinase Inhibitor-resistant Chinese Non-small Cell Lung Cancer
- (2009) Hua-Jun Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer
- (2009) Andrea Sartore-Bianchi et al. PLoS One
- c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases
- (2008) Zhao-Shi Zeng et al. CANCER LETTERS
- The Relative Distribution of Membranous and Cytoplasmic Met Is a Prognostic Indicator in Stage I and II Colon Cancer
- (2008) F. Ginty et al. CLINICAL CANCER RESEARCH
- Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer
- (2008) L. Toschi et al. CLINICAL CANCER RESEARCH
- The Prognostic Significance of RON and MET Receptor Coexpression in Patients with Colorectal Cancer
- (2008) Chung-Ta Lee et al. DISEASES OF THE COLON & RECTUM
- Molecular cancer therapy: Can our expectation be MET?
- (2008) Cristina Migliore et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started